Pharmacological characterization of the metabotropic glutamate receptor inhibiting D-[3H]-aspartate output in rat striatum - PubMed (original) (raw)

Pharmacological characterization of the metabotropic glutamate receptor inhibiting D-[3H]-aspartate output in rat striatum

G Lombardi et al. Br J Pharmacol. 1993 Dec.

Abstract

1. The effects of several agonists of the metabotropic glutamate receptor (mGluR) were studied in adult rat striatal slices by measuring (i) KCl (30 mM)-induced output of previously taken up D-[3H]-aspartate (Asp), (ii) forskolin (30 microM)-induced adenosine 3':5'-cyclic monophosphate (cyclic AMP) accumulation and (iii) phophoinositide (PI) hydrolysis. 2. K(+)-induced efflux of D-[3H]-Asp was inhibited by the following mGluR agonists: (1S,3S,4S)-(carboxycyclopropyl)glycine (L-CCG-I), (1S,3R)-1-aminocyclopentane-1,3-dicarboxylic acid (1S,3R-ACPD) and quisqualic acid (Quis). 2-Amino-4-phosphonobutyrate (L-AP4) was inactive up to 300 microM. The maximal inhibition of D-[3H]-Asp output was 60 +/- 8%. The EC50s of mGluR agonists were: 0.5 microM for L-CCG-I, 100 microM for 1S,3R-ACPD and 100 microM for Quis. 3. Forskolin-induced cyclic AMP accumulation was also inhibited by mGluR agonists. The maximal inhibition was 50 +/- 4% and was obtained at a concentration of 10 microM for L-CCG-I and 100 microM for 1S,3R-ACPD. The EC50s for this inhibition were: 0.9 microM for L-CCG-I and 20 microM for 1S,3R-ACPD. Quis (300 microM) inhibited cyclic AMP accumulation by approximately 20%. L-AP4 slightly potentiated cyclic AMP accumulation. 4. PI hydrolysis was stimulated by mGluR agonists. The most potent compound was Quis (100 microM), which increased inositol phosphate formation up to 2.2 fold over control values. Its EC50 was 15 microM. L-CCG-I and 1S,3R-ACPD increased inositol phosphate formation by approximately 1.8 fold and their EC50 values were 30 and 25 microM, respectively. L-AP4 did not affect PI hydrolysis. 5. In conclusion, mGluR agonists that reduce D-[3H]-Asp output have a pharmacological profile similar to that of mGluR agonists inhibiting cyclic AMP accumulation. L-CCG-I appears to be a relatively selective agonist for the mGluR receptor which inhibits D-[3H]-Asp efflux and cyclic AMP accumulation,while Quis appears to act preferentially on the mGluR receptor linked to the metabolism of PIs.

PubMed Disclaimer

Similar articles

• Modulation of cyclic AMP formation by putative metabotropic receptor agonists.
  Cartmell J, Kemp JA, Alexander SP, Shinozaki H, Kendall DA. Cartmell J, et al. Br J Pharmacol. 1994 Jan;111(1):364-9. doi: 10.1111/j.1476-5381.1994.tb14069.x. Br J Pharmacol. 1994. PMID: 8012720 Free PMC article.
• The enhancement and the inhibition of noradrenaline-induced cyclic AMP accumulation in rat brain by stimulation of metabotropic glutamate receptors.
  Pilc A, Legutko B, Czyrak A. Pilc A, et al. Prog Neuropsychopharmacol Biol Psychiatry. 1996 May;20(4):673-90. doi: 10.1016/0278-5846(96)00040-1. Prog Neuropsychopharmacol Biol Psychiatry. 1996. PMID: 8843491
• Structure-activity relationships for a series of phenylglycine derivatives acting at metabotropic glutamate receptors (mGluRs).
  Bedingfield JS, Kemp MC, Jane DE, Tse HW, Roberts PJ, Watkins JC. Bedingfield JS, et al. Br J Pharmacol. 1995 Dec;116(8):3323-9. doi: 10.1111/j.1476-5381.1995.tb15142.x. Br J Pharmacol. 1995. PMID: 8719814 Free PMC article.
• A metabotropic L-glutamate receptor agonist: pharmacological difference between rat central neurones and crayfish neuromuscular junctions.
  Shinozaki H, Ishida M. Shinozaki H, et al. Comp Biochem Physiol C Comp Pharmacol Toxicol. 1992 Sep;103(1):13-7. doi: 10.1016/0742-8413(92)90220-2. Comp Biochem Physiol C Comp Pharmacol Toxicol. 1992. PMID: 1360366 Review.
• [Pharmacology of the glutamate receptor].
  Shinozaki H. Shinozaki H. Nihon Yakurigaku Zasshi. 2000 Sep;116(3):125-31. doi: 10.1254/fpj.116.125. Nihon Yakurigaku Zasshi. 2000. PMID: 11031741 Review. Japanese.

Cited by

• Inhibition of presynaptic calcium transients in cortical inputs to the dorsolateral striatum by metabotropic GABA(B) and mGlu2/3 receptors.
  Kupferschmidt DA, Lovinger DM. Kupferschmidt DA, et al. J Physiol. 2015 May 15;593(10):2295-310. doi: 10.1113/JP270045. Epub 2015 Apr 13. J Physiol. 2015. PMID: 25781000 Free PMC article.
• Metabotropic glutamate receptors, transmitter output and fatty acids: studies in rat brain slices.
  Lombardi G, Leonardi P, Moroni F. Lombardi G, et al. Br J Pharmacol. 1996 Jan;117(1):189-95. doi: 10.1111/j.1476-5381.1996.tb15173.x. Br J Pharmacol. 1996. PMID: 8825362 Free PMC article.
• Pharmacological characterization of metabotropic glutamate receptors potentiating NMDA responses in mouse cortical wedge preparations.
  Mannaioni G, Carlà V, Moroni F. Mannaioni G, et al. Br J Pharmacol. 1996 Jul;118(6):1530-6. doi: 10.1111/j.1476-5381.1996.tb15570.x. Br J Pharmacol. 1996. PMID: 8832082 Free PMC article.
• Neuroprotection against hypoxic/hypoglycaemic injury after the insult by the group III metabotropic glutamate receptor agonist (R, S)-4-phosphonophenylglycine.
  Sabelhaus CF, Schröder UH, Breder J, Henrich-Noack P, Reymann KG. Sabelhaus CF, et al. Br J Pharmacol. 2000 Oct;131(4):655-8. doi: 10.1038/sj.bjp.0703646. Br J Pharmacol. 2000. PMID: 11030711 Free PMC article.
• Activation of type 5 metabotropic glutamate receptors enhances NMDA responses in mice cortical wedges.
  Attucci S, Carlà V, Mannaioni G, Moroni F. Attucci S, et al. Br J Pharmacol. 2001 Feb;132(4):799-806. doi: 10.1038/sj.bjp.0703904. Br J Pharmacol. 2001. PMID: 11181420 Free PMC article.

References

1. 1. Eur J Pharmacol. 1978 Mar 15;48(2):179-93 - PubMed
2. 1. Neurosci Lett. 1991 Aug 5;129(1):17-21 - PubMed
3. 1. Neurosci Lett. 1979 May;12(2-3):349-54 - PubMed
4. 1. J Neurochem. 1981 May;36(5):1691-9 - PubMed
5. 1. Nature. 1981 Jun 18;291(5816):593-4 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Europe PubMed Central
  • PubMed Central
  • Wiley

• Other Literature Sources

  • The Lens - Patent Citations Database

• Research Materials

  • NCI CPTC Antibody Characterization Program

• Miscellaneous

  • NCI CPTAC Assay Portal